Woodstock Corp’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Woodstock Corp’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-26,227	Closed	-$164K	–	159
2015 Q3	$164K	Hold	26,227	–	–	0.04%	146
2015 Q2	$260K	Hold	26,227	–	–	0.05%	146
2015 Q1	$193K	Hold	26,227	–	–	0.04%	160
2014 Q4	$140K	Hold	26,227	–	–	0.03%	164
2014 Q3	$132K	Sell	26,227 -3,200	-11%	-$19.7K	0.03%	162
2014 Q2	$197K	Sell	29,427 -5,700	-16%	-$36.3K	0.03%	165
2014 Q1	$254K	Sell	35,127 -13,457	-28%	-$79.8K	0.05%	152
2013 Q4	$183K	Buy	48,584 +4,000	+9%	+$15.5K	0.03%	161
2013 Q3	$150K	Buy	44,584 +26,463	+146%	+$92.1K	0.03%	162
2013 Q2	$61K	Buy	+18,121	New	+$65.7K	0.01%	163

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodstock Corp's NWBO Position: Q4 2015 in Review

Woodstock Corp sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2015, closing a stake of 26,227 shares — an estimated $164K sold.

Woodstock Corp first reported a position in NWBO in Q2 2013 and held it in 10 quarters. The position peaked at $260K in Q2 2015. 80 funds tracked by Wall St. Rank hold NWBO as of Q4 2015.

Woodstock Corp reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2015 after selling out during the quarter.
Woodstock Corp sold 26,227 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2015, an estimated $164K.
Woodstock Corp first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 10 quarters.
Woodstock Corp's Northwest Biotherapeutics, Inc. Common stock position peaked at $260K in Q2 2015.
80 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2015.

Based on Woodstock Corp's 13F filing for Q4 2015, filed 11 Jan 2016.